{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:28:41Z","timestamp":1792610921954,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1136\/ard.59.2.125","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:45:32Z","timestamp":1027766732000},"page":"125-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Angiotensin converting enzyme in human synovium: increased stromal [125I]351A binding in rheumatoid arthritis"],"prefix":"10.1016","volume":"59","author":[{"given":"David Andrew","family":"Walsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Catravas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wharton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.59.2.125_bib1","series-title":"Mammalian ectoenzymes.","first-page":"169","article-title":"Cell surface peptidases.","author":"Kenny","year":"1987"},{"key":"10.1136\/ard.59.2.125_bib2","first-page":"205","article-title":"Angiotensin II receptors and angiotensin II receptor antagonists.","volume":"45","author":"Timmermans","year":"1993","journal-title":"Pharmacol Rev"},{"key":"10.1136\/ard.59.2.125_bib3","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.bjp.0701062","article-title":"Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma.","volume":"120","author":"Walsh","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1136\/ard.59.2.125_bib4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1006\/jmcc.1994.1098","article-title":"Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.","volume":"26","author":"Brilla","year":"1994","journal-title":"J Mol Cell Cardiol"},{"key":"10.1136\/ard.59.2.125_bib5","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1161\/01.CIR.98.23.2553","article-title":"Expression of functional angiotensin-converting enzyme and AT1 receptors in cultured human cardiac fibroblasts.","volume":"98","author":"Hafizi","year":"1998","journal-title":"Circulation"},{"key":"10.1136\/ard.59.2.125_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.73.3.413","article-title":"Molecular characterization of angiotensin II\u2014induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.","volume":"73","author":"Sadoshima","year":"1993","journal-title":"Circ Res"},{"key":"10.1136\/ard.59.2.125_bib7","doi-asserted-by":"crossref","first-page":"C910","DOI":"10.1152\/ajpcell.1995.268.4.C910","article-title":"Norepinephrine and ANG II stimulate secretion of TGF-beta by neonatal rat cardiac fibroblasts in vitro.","volume":"268","author":"Fisher","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1136\/ard.59.2.125_bib8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-2143(96)90170-5","article-title":"Angiotensin-converting enzyme and wound healing in diverse tissues of the rat.","volume":"127","author":"Sun","year":"1996","journal-title":"J Lab Clin Med"},{"key":"10.1136\/ard.59.2.125_bib9","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/cvr\/28.9.1423","article-title":"Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat.","volume":"28","author":"Sun","year":"1994","journal-title":"Cardiovasc Res"},{"key":"10.1136\/ard.59.2.125_bib10","first-page":"S221","article-title":"Macrophage and myofibroblast proliferation in remnant kidney: role of angiotensin II.","volume":"63","author":"Wu","year":"1997","journal-title":"Kidney Int"},{"key":"10.1136\/ard.59.2.125_bib11","first-page":"772","article-title":"Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content.","volume":"20","author":"Smits","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1136\/ard.59.2.125_bib12","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0022-2828(91)90082-W","article-title":"DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril.","volume":"23","author":"van Krimpen","year":"1991","journal-title":"J Mol Cell Cardiol"},{"key":"10.1136\/ard.59.2.125_bib13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI118838","article-title":"Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.","volume":"98","author":"Volpert","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.59.2.125_bib14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/ard.45.11.921","article-title":"Serum and synovial fluid levels of angiotensin converting enzyme in polyarthritis.","volume":"45","author":"Lowe","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.59.2.125_bib15","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.51.4.476","article-title":"Production of angiotensin converting enzyme by rheumatoid synovial membrane.","volume":"51","author":"Veale","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.59.2.125_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9149(90)90118-K","article-title":"Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.","volume":"65","author":"Unger","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1136\/ard.59.2.125_bib17","first-page":"1610","article-title":"Neuropeptide degrading enzymes in normal and inflamed human synovium.","volume":"142","author":"Walsh","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.59.2.125_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1440-1681.1984.tb00294.x","article-title":"Localization of angiotensin converting enzyme in rat forebrain and other tissues by in vitro autoradiography using 125I-labelled MK351A.","volume":"11","author":"Mendelsohn","year":"1984","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1136\/ard.59.2.125_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0006-8993(91)91289-D","article-title":"Comparative quantification of rat brain and pituitary angiotensin-converting enzyme with autoradiographic and enzymatic methods.","volume":"545","author":"Correa","year":"1991","journal-title":"Brain Res"},{"key":"10.1136\/ard.59.2.125_bib20","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.2.125_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.2.125_bib22","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/clinchem\/30.5.696","article-title":"Inhibitor binding assay for angiotensin-converting enzyme.","volume":"30","author":"Fyhrquist","year":"1984","journal-title":"Clin Chem"},{"key":"10.1136\/ard.59.2.125_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-4165(73)90203-1","article-title":"Prolonged retention of high specific activity by 125I-labeled angiotensin II\u2014a consequence of \u2018decay catastrophe\u2019.","volume":"313","author":"Catt","year":"1973","journal-title":"Biochim Biophys Acta"},{"key":"10.1136\/ard.59.2.125_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0014-5793(93)81502-Q","article-title":"Mosaic expression of membrane peptidases by confluent cultures of Caco-2 cells.","volume":"317","author":"Howell","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1136\/ard.59.2.125_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","article-title":"Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.","volume":"29","author":"Hsu","year":"1981","journal-title":"J Histochem Cytochem"},{"key":"10.1136\/ard.59.2.125_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0304-3940(88)90346-1","article-title":"The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system.","volume":"85","author":"Shu","year":"1988","journal-title":"Neurosci Lett"},{"key":"10.1136\/ard.59.2.125_bib27","first-page":"691","article-title":"Focally regulated endothelial proliferation and cell death in human synovium.","volume":"152","author":"Walsh","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.59.2.125_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0008-6363(96)88516-6","article-title":"Cardiac angiotensin converting enzyme overproduction indicates interstitial activation in renovascular hypertension.","volume":"30","author":"Challah","year":"1995","journal-title":"Cardiovasc Res"},{"key":"10.1136\/ard.59.2.125_bib29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/BF02796341","article-title":"Angiotensin I-converting enzyme localization on cultured fibroblasts by immunofluorescence.","volume":"18","author":"Weinberg","year":"1982","journal-title":"In Vitro"},{"key":"10.1136\/ard.59.2.125_bib30","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1006\/jmcc.1997.0376","article-title":"Cultured myofibroblasts generate angiotensin peptides de novo.","volume":"29","author":"Katwa","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"10.1136\/ard.59.2.125_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/01902148209063288","article-title":"Angiotensin-converting enzyme substrates hydrolyzed by fibroblasts and vascular endothelial cells.","volume":"3","author":"Rubin","year":"1982","journal-title":"Exp Lung Res"},{"key":"10.1136\/ard.59.2.125_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-3565(24)37201-5","article-title":"Differential distribution of angiotensin AT2 receptors in the normal and failing human heart.","volume":"284","author":"Wharton","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1136\/ard.59.2.125_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00290261","article-title":"Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis, and systemic lupus erythematosus.","volume":"12","author":"Metsarinne","year":"1992","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard.59.2.125_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1507\/endocrj1954.39.259","article-title":"Prorenin-renin axis in synovial fluid in patients with rheumatoid arthritis and osteoarthritis.","volume":"39","author":"Izai","year":"1992","journal-title":"Endocrinol Jpn"},{"key":"10.1136\/ard.59.2.125_bib35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1476-5381.1994.tb13091.x","article-title":"AT1 receptor characteristics of angiotensin analogue binding in human synovium.","volume":"112","author":"Walsh","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1136\/ard.59.2.125_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease.","volume":"1","author":"Folkman","year":"1995","journal-title":"Nat Med"},{"key":"10.1136\/ard.59.2.125_bib37","series-title":"The kinin system.","first-page":"301","article-title":"Bradykinin as a growth factor.","author":"Walsh","year":"1997"},{"key":"10.1136\/ard.59.2.125_bib38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1476-5381.1993.tb13769.x","article-title":"Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists.","volume":"110","author":"Fan","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1136\/ard.59.2.125_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/315061a0","article-title":"Stimulation of connective tissue cell growth by substance P and substance K.","volume":"315","author":"Nilsson","year":"1985","journal-title":"Nature"},{"key":"10.1136\/ard.59.2.125_bib40","first-page":"951","article-title":"Microvascular substance P binding to normal and inflamed rat and human synovium.","volume":"267","author":"Walsh","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1136\/ard.59.2.125_bib41","first-page":"384","article-title":"Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1.","volume":"260","author":"Bathon","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1136\/ard.59.2.125_bib42","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(84)91821-X","article-title":"Captopril: a new treatment for rheumatoid arthritis?","volume":"i","author":"Martin","year":"1984","journal-title":"Lancet"},{"key":"10.1136\/ard.59.2.125_bib43","first-page":"603","article-title":"A clinical and biochemical assessment of a nonthiol ACE inhibitor (pentopril; CGS-13945) in active rheumatoid arthritis.","volume":"17","author":"Bird","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.59.2.125_bib44","first-page":"1605","article-title":"Influence of the new angiotensin converting enzyme inhibitor ramipril on several models of acute inflammation and the adjuvant arthritis in the rat.","volume":"36","author":"Caspritz","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"10.1136\/ard.59.2.125_bib45","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1476-5381.1990.tb15837.x","article-title":"Angiotensin converting enzyme inhibitors potentiate the bronchoconstriction induced by substance P in the guinea-pig.","volume":"100","author":"Subissi","year":"1990","journal-title":"Br J Pharmacol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724385036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724385036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.59.2.125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T02:46:41Z","timestamp":1736131601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724385036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["S0003496724385036"],"URL":"https:\/\/doi.org\/10.1136\/ard.59.2.125","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2000,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin converting enzyme in human synovium: increased stromal [125I]351A binding in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.59.2.125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}